United Press International - Health Business - Bayer's Trasylol may cause kidney failure: "WASHINGTON, Jan. 25 (UPI) -- A major independent study indicates Bayer's antifibrinolytic agent Trasylol doubles the risk of kidney failure and causes other serious adverse events, including stroke and heart attack.
The finding is likely to significantly impact sales of the drug, which were expected to be more than $600 million this year."
